Key facts
- It has raised $2.0M; the latest was Later Stage VC ($120K) in Jan 2026.
- Notable investors include European Commission, DeveloPPP Ventures, Healthtech Hub, DutchBasecamp, Everis Awards — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for GOAL 3
- ·The full record, as it builds
Funding rounds
No funding rounds for GOAL 3 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GOAL 3
Developer of patient monitoring systems intended for environments with limited resources. The company offers healthcare technologies and devices such as patient monitoring gadgets used to measure the vital signs of newborns in low-resource settings, predictive algorithms for monitoring systems to help make better judgments, and a patient monitoring platform where algorithms can be developed, enabling patients, doctors, research institutes to access healthcare facilities and get treatment for critical diseases.
- Sector
- Healthcare
- HQ
- S-Hertogenbosch, Netherlands
- Founded
- 2019
- Employees
- 29
- Website
- goal3.org/
- Ownership
- Privately Held (backing)
GOAL 3 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GOAL 3 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GOAL 3 in its N-PORT filings yet. We sweep new filings monthly.